The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial

INTRODUCTION: Gabapentin, a neurotransmitter modulator, is thought to treat refractory cough associated with interstitial lung disease by improving cough hypersensitivity. METHODS/DESIGN: This is a single-center, prospective, randomized, double-blind, placebo-controlled trial. The trial will investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ronglin, Xu, Xianghuai, Wang, Shengyuan, Pu, Jincheng, Shi, Cuiqin, Wen, Siwan, Zhu, Yiqing, Tang, Jianping, Wang, Xuan, Yu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862465/
https://www.ncbi.nlm.nih.gov/pubmed/35189953
http://dx.doi.org/10.1186/s13063-022-06059-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862465/
https://www.ncbi.nlm.nih.gov/pubmed/35189953
http://dx.doi.org/10.1186/s13063-022-06059-5

Ejemplares similares